Dennis L. Andress

8.2k total citations · 2 hit papers
90 papers, 5.2k citations indexed

About

Dennis L. Andress is a scholar working on Nephrology, Nutrition and Dietetics and Pathology and Forensic Medicine. According to data from OpenAlex, Dennis L. Andress has authored 90 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Nephrology, 22 papers in Nutrition and Dietetics and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Dennis L. Andress's work include Parathyroid Disorders and Treatments (34 papers), Vitamin D Research Studies (17 papers) and Trace Elements in Health (17 papers). Dennis L. Andress is often cited by papers focused on Parathyroid Disorders and Treatments (34 papers), Vitamin D Research Studies (17 papers) and Trace Elements in Health (17 papers). Dennis L. Andress collaborates with scholars based in United States, Netherlands and United Kingdom. Dennis L. Andress's co-authors include Donald J. Sherrard, Bryan Kestenbaum, Stephen L. Seliger, Joshua N. Sampson, Bessie A. Young, Kyle Rudser, Donald J. Patterson, Yili Pritchett, Daniel W. Coyne and Norma A. Maloney and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Dennis L. Andress

88 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease

2004 919 citations Bryan Kestenbaum, Joshua N. Sampson et al. Journal of the American Society of Nephrology profile →
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

2010 520 citations Dick de Zeeuw, Rajiv Agarwal et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis L. Andress United States	39	2.9k	1.3k	1.2k	953	667	90	5.2k
Jaime Herrera-Acosta Mexico	34	3.3k 1.2×	1.6k 1.2×	876 0.7×	1.6k 1.6×	1.1k 1.7×	77	6.4k
Marc Vervloet Netherlands	43	4.5k 1.6×	1.2k 1.0×	1.5k 1.3×	577 0.6×	799 1.2×	189	6.7k
Martin H. de Borst Netherlands	39	2.1k 0.7×	796 0.6×	1.1k 0.9×	407 0.4×	833 1.2×	260	4.8k
Hirotoshi Morii Japan	37	2.2k 0.8×	770 0.6×	720 0.6×	919 1.0×	1.3k 1.9×	169	5.8k
José Manuel Valdivielso Spain	39	1.8k 0.6×	1.3k 1.0×	698 0.6×	793 0.8×	1.2k 1.9×	181	6.0k
Eiji Ishimura Japan	44	3.1k 1.1×	822 0.7×	597 0.5×	1.7k 1.8×	786 1.2×	180	6.9k
Christiane Drechsler Germany	42	1.6k 0.6×	1.2k 0.9×	706 0.6×	1.3k 1.4×	554 0.8×	124	5.3k
Sharon G. Adler United States	43	3.1k 1.1×	689 0.5×	295 0.2×	921 1.0×	1.1k 1.6×	113	5.7k
Hideki Hirakata Japan	43	2.7k 1.0×	695 0.6×	323 0.3×	541 0.6×	660 1.0×	161	5.8k
Daniel W. Coyne United States	39	2.4k 0.8×	959 0.8×	568 0.5×	285 0.3×	247 0.4×	122	5.1k

Countries citing papers authored by Dennis L. Andress

Since Specialization

Citations

This map shows the geographic impact of Dennis L. Andress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis L. Andress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis L. Andress more than expected).

Fields of papers citing papers by Dennis L. Andress

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis L. Andress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis L. Andress. The network helps show where Dennis L. Andress may publish in the future.

Co-authorship network of co-authors of Dennis L. Andress

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis L. Andress. A scholar is included among the top collaborators of Dennis L. Andress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis L. Andress. Dennis L. Andress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeeuw, Dick de, Dennis L. Andress, Maarten J. Bijlsma, et al.. (2015). Number and Frequency of Albuminuria Measurements in Clinical Trials in Diabetic Nephropathy. Clinical Journal of the American Society of Nephrology. 10(3). 410–416. 16 indexed citations

Zager, Richard A., Ali C.M. Johnson, Dennis L. Andress, & K Becker. (2013). Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury. Kidney International. 84(4). 703–712. 90 indexed citations

Patel, Neha M., Orlando M. Gutiérrez, Dennis L. Andress, et al.. (2010). Vitamin D deficiency and anemia in early chronic kidney disease. Kidney International. 77(8). 715–720. 100 indexed citations

Zeeuw, Dick de, Rajiv Agarwal, Michael Amdahl, et al.. (2010). Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. The Lancet. 376(9752). 1543–1551. 520 indexed citations breakdown →

Schumock, Glen T., Dennis L. Andress, Steven E. Marx, et al.. (2008). Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients. Current Medical Research and Opinion. 24(11). 3037–3048. 33 indexed citations

Coyne, Daniel W., Muralidhar Acharya, Ping Qiu, et al.. (2006). Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD. American Journal of Kidney Diseases. 47(2). 263–276. 146 indexed citations

Kestenbaum, Bryan, Joshua N. Sampson, Kyle Rudser, et al.. (2004). Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease. Journal of the American Society of Nephrology. 16(2). 520–528. 919 indexed citations breakdown →

Matsumura, Masazumi, Ami S. Bhatt, Dennis L. Andress, et al.. (2004). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. The Prostate. 62(1). 1–13. 77 indexed citations

Andress, Dennis L., et al.. (2003). Vitamin D analogs in uremia: integrating medical and nutritional issues. Advances in Renal Replacement Therapy. 10(3). 241–247. 1 indexed citations

10.

Andress, Dennis L.. (2002). Lower Target Calcium Levels in Dialysis Patients. Seminars in Dialysis. 15(1). 74–74. 1 indexed citations

11.

Andress, Dennis L.. (2001). Intravenous versus oral vitamin D therapy in dialysis patients: What is the question?. American Journal of Kidney Diseases. 38(5). S41–S44. 14 indexed citations

12.

Sherrard, Donald J., et al.. (1998). A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure: Rapid Communication. Kidney International. 53(1). 223–227. 114 indexed citations

13.

McNeil, Julian, et al.. (1998). Regulation of Insulin-Like Growth Factor-Binding Protein-5 by Insulin-Like Growth Factor I and Interleukin-1α in Ovine Articular Chondrocytes*. Endocrinology. 139(5). 2356–2362. 40 indexed citations

14.

McNeil, Julian, et al.. (1998). Insulin-like growth factor binding protein-5 proteolytic activity in ovine articular chondrocyte culture. Biochimica et Biophysica Acta (BBA) - General Subjects. 1425(3). 567–576. 8 indexed citations

15.

Andress, Dennis L., et al.. (1991). Beta2-microglobulin deposition in bone in chronic renal failure. Kidney International. 39(5). 990–995. 23 indexed citations

16.

Andress, Dennis L. & Roger S. Birnbaum. (1991). A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochemical and Biophysical Research Communications. 176(1). 213–218. 67 indexed citations

17.

Ott, Susan M., Dennis L. Andress, & Donald J. Sherrard. (1986). Bone Oxalate in a Long-Term Hemodialysis Patient Who Ingested High Doses of Vitamin C. American Journal of Kidney Diseases. 8(6). 450–454. 11 indexed citations

18.

Andress, Dennis L., Susan M. Ott, Norma A. Maloney, & Donald J. Sherrard. (1985). Effect of Parathyroidectomy on Bone Aluminum Accumulation in Chronic Renal Failure. New England Journal of Medicine. 312(8). 468–473. 105 indexed citations

19.

Milliner, Dawn S., Henry G. Nebeker, Susan M. Ott, et al.. (1984). Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related Osteodystrophy. Annals of Internal Medicine. 101(6). 775–780. 116 indexed citations

20.

Andress, Dennis L., et al.. (1984). Phosphorus administration in patients with profound hypophosphatemia. Kidney International. 25(3). 551–556. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact